Latigo Biotherapeutics Inc.
Status: Publicly traded
Last reviewed: October 2026
Direct answer
Latigo Biotherapeutics Inc. is publicly traded on NASDAQ under the ticker LTGO.
Latigo Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company committed to developing innovative non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its products include Molecule: LTG-001, Molecule: LTG-32, Molecule: LTG-001 IV and Molecule: LTG-418. The company was founded on November 20, 2018 and is headquartered in Thousand Oak,...
Can you invest in Latigo Biotherapeutics Inc.?
Yes. Latigo Biotherapeutics Inc. is publicly traded on NASDAQ under the ticker LTGO.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Latigo Biotherapeutics Inc.
Detailed equity research is provided by MarketSnap.